Bollinger Shipyards, a prominent maritime construction and repair company, is once again at the center of a federal lawsuit filed by the U.S. Equal Employment Opportunity Commission (EEOC), alleging that the employer unlawfully disqualified five job candidates from its application process due to their use of legally prescribed medications. This legal action, announced on October 1, 2026, marks the second such lawsuit against the Louisiana-based shipyard within a year, underscoring a persistent challenge to employer practices regarding pre-employment medical screenings and disability discrimination under the Americans with Disabilities Act (ADA).
The core of the EEOC’s allegations revolves around Bollinger Shipyards’ post-offer, pre-employment examination process, conducted by a third-party medical clinic. According to the lawsuit, five prospective hires were rejected after disclosing their use of legally prescribed medications, including Suboxone, a drug commonly used in the treatment of opioid use disorder (OUD). The EEOC contends that the clinic personnel and, by extension, Bollinger Shipyards, failed to conduct individualized assessments of the candidates’ ability to perform "safety-sensitive" roles, instead relying on blanket assumptions based on their medication use. This alleged practice directly violates the ADA, which prohibits discrimination against qualified individuals with disabilities.
Background of the Ongoing Legal Challenges
This latest lawsuit is not an isolated incident but rather a continuation of a pattern of alleged discriminatory practices at Bollinger Shipyards. Just last September, the EEOC filed a similar lawsuit against the company, also concerning disability discrimination. In that prior action, the EEOC’s Birmingham district regional attorney emphasized the agency’s commitment to "vigorously enforce" the ADA, calling it an "indispensable" law designed to protect individuals with disabilities from employment discrimination. The recurrence of these allegations suggests a systemic issue within Bollinger Shipyards’ hiring protocols, particularly concerning candidates managing health conditions with prescription medications.
The specific focus on Suboxone in the current lawsuit highlights a critical intersection of public health and employment law. Suboxone, a combination of buprenorphine and naloxone, is an FDA-approved medication that helps individuals manage opioid dependence by reducing cravings and withdrawal symptoms, allowing them to stabilize their lives and often return to productive employment. Discrimination against individuals using such medication, even for legitimate medical purposes, can hinder recovery efforts and perpetuate stigma, effectively barring a segment of the workforce from gainful employment despite their qualifications and stability.
Allegations of Flawed Hiring and Onboarding Protocols
The EEOC’s complaint details significant deficiencies in Bollinger Shipyards’ hiring and onboarding process. Once a job offer was extended, candidates were required to undergo a pre-employment examination at an external medical clinic. During these examinations, the potential hires were mandated to disclose all legally prescribed medications they were taking and provide corresponding medical records.
Crucially, the EEOC alleges that the clinic personnel responsible for these evaluations failed to conduct a thorough and individualized assessment of each candidate. Specifically, they are accused of:
- Lack of Verification: Not verifying whether each candidate was currently using all medications listed in their medical records, or if their usage patterns had changed.
- Impact on Work Hours: Not investigating whether the medications were taken during work hours or at times that could affect work performance.
- Side Effects Assessment: Failing to adequately assess the actual side effects experienced by each candidate, rather than relying on a general list of potential side effects provided by drug manufacturers.
- Ability to Perform Job Functions: Not evaluating whether the candidates felt they could safely handle the "safety-sensitive" aspects of the job while on their medication.
- Direct Threat Determination: Significantly, the agency claimed that the clinic personnel who conducted these pre-employment exams never marked the box on the report indicating that any of these hires "posed a direct threat to themselves or others." This omission is particularly damning, as the "direct threat" defense is a high bar for employers to meet under the ADA, requiring an individualized assessment of a significant risk of substantial harm that cannot be eliminated or reduced by reasonable accommodation.
These alleged failures underscore a fundamental misunderstanding or disregard of ADA requirements, which mandate that employers assess a candidate’s current ability to perform essential job functions, with or without reasonable accommodation, rather than making broad generalizations based on medical conditions or prescribed treatments.
The Americans with Disabilities Act and Employer Obligations
The Americans with Disabilities Act (ADA), enacted in 1990 and amended in 2008, is a comprehensive civil rights law that prohibits discrimination based on disability. Under the ADA, an employer cannot discriminate against a qualified individual with a disability regarding hiring, promotion, discharge, compensation, training, or other terms, conditions, and privileges of employment. A "qualified individual with a disability" is a person who, with or without reasonable accommodation, can perform the essential functions of the employment position that such individual holds or desires.
The ADA’s protections extend to individuals with a history of disability, those perceived as having a disability, and those currently managing a disability, including individuals in recovery from substance use disorders who are receiving medically supervised treatment. When it comes to pre-employment medical examinations, the ADA sets strict guidelines:
- Pre-Offer Stage: Employers generally cannot ask disability-related questions or require medical exams before a job offer is made.
- Post-Offer Stage: After a job offer has been extended, employers can require medical examinations and ask disability-related questions, provided that all entering employees in the same job category are subjected to the same requirements. However, any offer can only be withdrawn if the results of the medical examination show that the individual cannot perform the essential functions of the job, even with reasonable accommodation, or poses a "direct threat" to the health or safety of themselves or others.
The "direct threat" standard is critical. It requires an employer to show a significant risk of substantial harm to the health or safety of the individual or others that cannot be eliminated or reduced by reasonable accommodation. This determination must be based on an individualized assessment of the individual’s present ability to safely perform the essential functions of the job. Factors to consider include: the duration of the risk; the nature and severity of the potential harm; the likelihood that the potential harm will occur; and the imminence of the potential harm. Relying on generalized fears, stereotypes, or a drug manufacturer’s list of potential side effects, as alleged against Bollinger Shipyards, is insufficient and violates the ADA.
The Civil Rights Act of 1991, also cited in the EEOC’s complaint, strengthens federal civil rights laws, providing for the right to a jury trial and monetary damages in cases of intentional employment discrimination, including under the ADA.
Broader Context: The Opioid Crisis and Workforce Integration
The EEOC’s actions against Bollinger Shipyards take on added significance when viewed through the lens of the ongoing opioid crisis in the United States and efforts to facilitate workforce integration for individuals in recovery. The Department of Labor (DOL) has increasingly focused on the effects of opioid use in the workplace, implementing initiatives like the "Great Recovery Initiative" under previous administrations, which aims to address the issue by supporting recovery and employment.
Recent statements from federal officials underscore the dual challenge of combating illicit drug use while also supporting individuals in recovery. White House Drug Czar Sara Carter recently emphasized that "fighting back against the deadly synthetic opioids infecting the entire illicit drug supply" is a top priority for the administration. This focus on illicit drug supply is distinct from, but often conflated with, the medically supervised use of prescription medications for substance use disorder treatment.
The Occupational Safety and Health Administration (OSHA) has also highlighted the "pervasiveness of opioid use and abuse," stressing the critical importance of ensuring the American workforce is "familiar with drug overdose recognition and reversal." OSHA’s fact sheet on opioid emergencies primes employers for overdose preparedness strategies, including the proper use of naloxone or nalmefene and best practices for storing overdose kits in highly visible and easily accessible areas.
These initiatives demonstrate a federal commitment to addressing the opioid crisis comprehensively, which includes supporting individuals in recovery to re-enter or remain in the workforce. Discriminatory hiring practices that penalize individuals for legally prescribed medication, especially those for OUD, run counter to these broader public health and economic goals. Excluding these individuals not only violates their civil rights but also deprives employers of a valuable and often dedicated talent pool.
Data and Statistics on Disability Discrimination
Disability discrimination remains a significant issue in the American workplace. According to EEOC data, charges alleging disability discrimination consistently rank among the highest categories of discrimination claims filed each year. In fiscal year 2023, for instance, disability discrimination charges accounted for a substantial portion of all charges filed with the EEOC. While specific breakdowns for discrimination based on prescription drug use are not always readily available, cases involving medical examinations, inquiries, and the "direct threat" defense are frequently litigated under the ADA.
The shipbuilding and maritime industries, which often involve physically demanding and "safety-sensitive" roles, face particular scrutiny. Employers in these sectors have a legitimate interest in ensuring workplace safety. However, this interest must be balanced with the ADA’s requirements for individualized assessment. Studies have shown that individuals successfully managing conditions like OUD with medication can perform their jobs safely and effectively, often with no impairment to their work performance. Blanket exclusions based solely on medication use, without an individualized assessment, are not only unlawful but can also perpetuate harmful stereotypes and limit economic opportunities for a vulnerable population.
Implications for Employers and the Workforce
The EEOC’s renewed legal action against Bollinger Shipyards carries significant implications for employers nationwide, particularly those operating in industries with "safety-sensitive" positions.
- Enhanced Scrutiny: Employers can expect increased scrutiny from the EEOC regarding their pre-employment medical screening processes. The agency is clearly signaling that it will challenge practices that rely on blanket exclusions rather than individualized assessments.
- Training and Compliance: The lawsuits underscore the critical need for employers to thoroughly train their HR personnel, hiring managers, and any third-party medical clinics or providers on ADA compliance. This includes understanding the nuances of the "direct threat" standard, the importance of reasonable accommodation, and the prohibition against discrimination based on perceived disability or medically supervised treatment.
- Review of Policies: Companies should proactively review their hiring policies, particularly those related to medical examinations and drug screenings, to ensure they align with ADA requirements. This involves moving away from prescriptive lists of disqualifying medications and towards a more dynamic, individualized assessment framework.
- Workforce Integration: For individuals managing health conditions with medication, especially those in recovery from OUD, these lawsuits offer a glimmer of hope. They reinforce the legal protections available and challenge the stigma that often accompanies such conditions, advocating for their right to fair employment opportunities.
- Economic Impact: Excluding qualified workers based on unlawful criteria represents a loss of talent and productivity for employers. In a competitive labor market, employers who embrace inclusive hiring practices compliant with the ADA stand to benefit from a broader and more diverse applicant pool.
Announcing Wednesday’s lawsuit, acting EEOC Birmingham District Director Linda Sales-Long issued a clear caution to employers: "Employers cannot rely solely on drug manufacturers’ listing of potential side effects as proof that an applicant cannot safely perform a job." This statement encapsulates the core legal principle at stake: an employer’s assessment must be based on an individual’s actual abilities and risks, not on generic information or speculative fears.
As the legal proceedings against Bollinger Shipyards unfold, the outcome will likely serve as a crucial precedent and a renewed reminder of the vital importance of ADA compliance in fostering fair and equitable employment opportunities for all qualified individuals, including those who rely on legally prescribed medications to manage their health. The cases highlight the ongoing tension between legitimate safety concerns and the imperative to prevent discrimination, emphasizing that the ADA provides a clear framework for balancing these priorities through individualized, evidence-based assessments.
